SLV313 is a dopamine D2 receptor antagonist and serotonin...

SLV313 is a dopamine D2 receptor antagonist and serotonin 5-HT1A receptor agonist: In vitro and in vivo neuropharmacology

J. Glennon, A.C. McCreary, E. Ronken, R. Siarey, M.B. Hesselink, R. Feenstra, B. Van Vliet, S.K. Long, C.G. Kruse
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Year:
2002
Language:
english
DOI:
10.1016/s0924-977x(02)80381-9
File:
PDF, 125 KB
english, 2002
Conversion to is in progress
Conversion to is failed